bio børsten IVS: Financial statements 2019
CVR: 38028944
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
bio børsten IVS (CVR 38028944) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 1,464 and a net result of DKK -20,133 compared with DKK 13,696 the year before. That is a decrease of 93.7% compared with the year before. Equity in the 2019 report amounted to DKK 15,917. The solvency ratio was 55.6%.
- Gross Profit
- DKK 1,464
- Profit/Loss
- DKK -20,133
- Equity
- DKK 15,917
- Total Assets
- DKK 28,645
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Bio børsten IVS has published its annual report for 2018. Gross profit came to DKK 23,379, and the net result was DKK 13,696.
As of January 1, 2019, Ola Berger Bungum is registered as director of bio børsten IVS.
As of January 1, 2019, Ola Berger Bungum is registered as vice chairman of bio børsten IVS.
As of January 1, 2019, Frederik Hallengren is registered as chairman of bio børsten IVS.
About bio børsten IVS
bio børsten IVS was a Danish company of the type Iværksætterselskab based in København N, founded in 2016. The company has been dissolved on 5 December 2022. The company was registered under the industry Detailhandel med andre varer i.a.n.. In 2020, the company reported a gross profit of DKK 0 and a net result of DKK -8,023 compared with DKK -20,133 the year before. Equity in the 2020 report amounted to DKK 16,475.